A European study, reported Aug. 6 in The Lancet, finds that widespread use of prostate-specific antigen (PSA) blood tests does reduce deaths from the disease by about one-fifth.
Dr. Kathleen Cooney will present about the number of young men being diagnosed with aggressive prostate cancer.
Dr. J. Kellogg Parsons, of the UCSD Moores Cancer Center, said a MRI-guided prostate biopsy will enhance the patient experience by reducing the number of false-positive biopsies and resulting in earlier diagnosis when cancer is present.
PHEN President Thomas Farrington raised the issue of prostate cancer overtreatment in his book "Battling The Killer Within" in 2001. PHEN continues to address this issue aggressively...